Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution
Mabel Ryder(Mayo Clinic in Arizona), James A. Fagin(Memorial Sloan Kettering Cancer Center)
Cited by 439
Related Papers
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
|New England Journal of Medicine|2013|825
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
|Nature Genetics|2020|739
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
|Journal of Clinical Investigation|1993|653
Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|560
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020
|Journal of the National Comprehensive Cancer Network|2020|484